Release Date: 01/07/19 13:02 Summary: Expiry of Unlisted Options Price Sensitive: No Download Document 113.6KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%